Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas.
J Thorac Oncol. 2022 Aug;17(8):1050-1053. doi: 10.1016/j.jtho.2022.05.009. Epub 2022 Jun 28.
:AFF2 carcinomas of the head and neck region have been recently described and reported to have aggressive clinical behavior but exceptional sensitivity to immunotherapy. We report a case of a 26-year-old female, never smoker, with a 5.2-cm left lower lobe central lung mass, with morphologic features identical to those reported for DEK::AFF2 head and neck carcinomas, including mixed papillary exophytic and invasive components, squamous/basaloid features, and monomorphic cytomorphology. DEK (exon 7)::AFF2 (exon 9) fusion was identified by whole-transcriptome RNA sequencing. This is the first report of thoracic DEK::AFF2 carcinoma, indicating that these tumors are not confined to the head and neck region but can involve both upper and lower respiratory tracts. This entity should be considered in the differential diagnosis of squamous cell carcinomas in never smokers lacking other known oncogenic mutations.
:AFF2 头颈部癌最近被描述并报道,具有侵袭性的临床行为,但对免疫治疗有特殊的敏感性。我们报告了一例 26 岁的女性,从不吸烟,左肺下叶有一个 5.2 厘米的中央肺肿块,其形态特征与报道的 DEK::AFF2 头颈部癌相同,包括混合乳头状外生性和侵袭性成分、鳞状/基底样特征和单形细胞形态学。通过全转录组 RNA 测序鉴定出 DEK(外显子 7)::AFF2(外显子 9)融合。这是首例胸部 DEK::AFF2 癌的报告,表明这些肿瘤不仅局限于头颈部,还可以累及上下呼吸道。在没有其他已知致癌突变的从不吸烟的鳞状细胞癌的鉴别诊断中应考虑到这种实体。